DEA-Licensed Pharmaceutical Cannabis Company Biopharmaceutical Research Company (BRC) Announces $20M Series A Funding Round

 DEA-Licensed Pharmaceutical Cannabis Company Biopharmaceutical Research Company (BRC) Announces $20M Series A Funding Round

The Company will use the investment to scale up and increase product offering, conduct sponsored research, and execute on its go-to-market strategy
MONTEREY, Calif., Oct. 4, 2022 /PRNewswire/ — Bio…